Back to results
WithdrawnPhase 2

Clinical Trial of AGB101 for Mild Cognitive Impairment

NCT05986721

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Johns Hopkins

Baltimore, Maryland, United States

View on ClinicalTrials.gov
Clinical Trial of AGB101 for Mild Cognitive Impairment — TrialFind